{
  "applicationMetaData": {
    "filingDate": "2002-01-18T00:00:00",
    "effectiveFilingDate": "2002-01-18T00:00:00",
    "subclass": "401000",
    "groupArtUnitNumber": "1627",
    "firstInventorToFileIndicator": "N",
    "inventionSubjectMatterCategory": "UTL",
    "statusNumber": "163",
    "nationalStageIndicator": "N",
    "applicationStatusDescriptionText": "Abandoned  --  After Examiner's Answer or Board of Appeals Decision",
    "viewTypeCategory": "public",
    "applicationIdentification": {
      "applicationNumberText": "10052961         "
    },
    "customerNumber": "23432",
    "class": "514",
    "docketNumber": "44657-AAA-PCT-US/JPW",
    "applicationConfirmationNumber": "3958",
    "inventionTitle": "Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1",
    "applicationStatusDate": "2014-09-02T18:47:14",
    "applicationTypeCategory": "REGULAR",
    "status": "FAILURE"
  },
  "parentContinuityBag": [
    {
      "claimType": "CON",
      "patentNumber": "6670351",
      "publicIndicator": false,
      "parentApplicationNumberText": "09469817",
      "childApplicationNumberText": "09469817",
      "filingDate": "1999-12-22T00:00:00",
      "applicationStatusCategory": "250",
      "statusDescriptionText": "Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362",
      "aiaIndicator": false
    },
    {
      "claimType": "CON",
      "patentNumber": "6090799",
      "publicIndicator": false,
      "parentApplicationNumberText": "08244988",
      "childApplicationNumberText": "08244988",
      "filingDate": "1995-06-22T00:00:00",
      "applicationStatusCategory": "150",
      "statusDescriptionText": "Patented Case",
      "aiaIndicator": false
    },
    {
      "claimType": "NST",
      "patentNumber": null,
      "publicIndicator": false,
      "parentApplicationNumberText": "PCT/US93/10063",
      "childApplicationNumberText": "PCT/US93/10063",
      "filingDate": "1993-10-20T00:00:00",
      "applicationStatusCategory": "163",
      "statusDescriptionText": "Abandoned  --  After Examiner's Answer or Board of Appeals Decision",
      "aiaIndicator": false
    }
  ],
  "childContinuityBag": [
    {
      "claimType": "CON",
      "patentNumber": null,
      "publicIndicator": false,
      "parentApplicationNumberText": "10052961",
      "childApplicationNumberText": "10052961",
      "filingDate": "2007-03-20T00:00:00",
      "applicationStatusCategory": "161",
      "statusDescriptionText": "Abandoned  --  Failure to Respond to an Office Action",
      "aiaIndicator": false
    }
  ],
  "inventorBag": [
    {
      "nameLineOneText": "Joseph Berger",
      "firstName": "Joseph",
      "middleName": "R.",
      "lastName": "Berger",
      "cityName": "Miami",
      "geographicRegionName": "FLORIDA",
      "countryCode": "US"
    }
  ],
  "assigneeBag": [
    {
      "organizationStandardName": "BTG Pharmaceutical Corp."
    }
  ],
  "correspondenceAddress": {
    "nameLineOneText": "Gary J. Gershik; John P. White",
    "addressLineOneText": "405 LEXINGTON AVENUE",
    "cityName": "NEW YORK",
    "geographicRegionCode": "NY",
    "geographicRegionName": "NEW YORK",
    "countryCode": "US",
    "countryName": "UNITED STATES"
  },
  "entityStatusData": {
    "smallBusinessIndicator": false,
    "businessEntityStatusCategory": "SMALL"
  },
  "examinerDetails": {
    "givenName": "SHENGJUN",
    "middleName": null,
    "familyName": "WANG",
    "phoneNumber": null
  },
  "preGrantPublicationData": [
    {
      "ipOfficeCode": "US",
      "publicationYear": 2002,
      "publicationSequenceNumber": "0091155",
      "patentDocumentKindCode": "A1",
      "publicationDate": "2002-07-11T00:00:00"
    }
  ],
  "feePaymentHistory": [],
  "status": "SUCCESS"
}